Sort
39,280 grants matching “leukemia”
Molecular Digital CytoImaging for Leukemia Drug Screening
$581,084Tothu Q Vu · Oregon Health & Science University · R01 · FY2021 · CA
Immune Compromises Zebrafish for Cell Transplantation
$581,075David Michael Langenau · Massachusetts General Hospital · R24 · FY2014 · OD
VLA-4âtargeted 67Cu-LLP2A preconditioning enhances efficacy of T-cell-based adoptive immunotherapy
$580,985Ravi Bhasker Patel · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA
Asparagine Synthetase as a Biomarker for L-asparaginase Rx of Ovarian Cancer
$580,865John N Weinstein · Basic Sciences · Z01 · FY2007 · CA
Genetic Epidemiology of Chronic Lymphocytic Leukemia
$580,830Susan L Slager · Mayo Clinic Rochester · U01 · FY2013 · CA
Squamous Cell Carcinoma of the Lung: Validation of Molecular Signatures for Progn
$580,661Fred R Hirsch · University Of Colorado Denver · U01 · FY2014 · CA
Human-Enzyme Mediated, Systemic Depletion of Cystine for Cancer Treatment.
$580,448George Georgiou Georgiou · University Of Texas At Austin · R01 · FY2015 · CA
Human-Enzyme Mediated, Systemic Depletion of Cystine for Cancer Treatment.
$580,448George Georgiou Georgiou · University Of Texas At Austin · R01 · FY2014 · CA
Human-Enzyme Mediated, Systemic Depletion of Cystine for Cancer Treatment.
$580,448George Georgiou Georgiou · University Of Texas At Austin · R01 · FY2016 · CA
Human-Enzyme Mediated, Systemic Depletion of Cystine for Cancer Treatment.
$580,448George Georgiou Georgiou · University Of Texas At Austin · R01 · FY2017 · CA
Gene Therapy for Canine X-linked SCID
$580,425University Of Pennsylvania · R01 · FY2005 · AI
LEARNING IMPAIRMENTS AMONG SURVIVORS OF CHILDHOOD CANCER
$580,383St. Jude Children'S Research Hospital · R01 · FY2003 · CA
Modeling Tyrosine Kinase Inhibitor-Induced Vascular Dysfunction Using Human iPSCs
$580,336Joseph C Wu · Stanford University · R01 · FY2020 · HL
Chromatin mobility in response to DNA damage
$580,321Timothy Sebastian Pardee · Wake Forest University Health Sciences · U01 · FY2022 · CA
Protein-RNA interactions in cancer
$580,298Jeremy Robert Sanford · University Of California Santa Cruz · R01 · FY2024 · CA
Novel Biomarkers to Risk-Stratify AML Patients with NPM1^Pos/FLT3-IT^Neg Genotype
$580,264Derek L Stirewalt · Fred Hutchinson Cancer Research Center · R01 · FY2018 · CA
Clinical treatment of advanced Merkel cell carcinoma
$580,211Isaac Brownell · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2025 · AR
Down syndrome: Bridging Genes, Brain and Cognition
$580,052Julie R Korenberg · University Of Utah · R01 · FY2016 · HD
SWOG Community Clinical Oncology Program Research Base
$579,978Charles D. Blanke · Oregon Health & Science University · U10 · FY2014 · CA
Genetics-guided Individualization of Thiopurine Therapy
$579,917Jun J. Yang · St. Jude Children'S Research Hospital · R01 · FY2017 · GM
Enhancing efficacy of virus-specific T cell therapy following hematopoietic stem cell transplantation by CD52 knockout
$579,879Michael Daniel Keller · Children'S Research Institute · R33 · FY2025 · HL
The non-catalytic function of PARP2 in DNA repair and cancer therapy
$579,845Shan Zha · Columbia University Health Sciences · R01 · FY2023 · CA
Endothelial Regeneration Following Lung Vascular Injury
$579,810Asrar B. Malik · University Of Illinois At Chicago · R01 · FY2014 · HL
Endothelial Regeneration Following Lung Vascular Injury
$579,810Asrar B. Malik · University Of Illinois At Chicago · R01 · FY2016 · HL
Genomics of Acute myelogenous leukemia (AML): Whole Genome Resequencing
$579,788Richard K. Wilson · Washington University · P01 · FY2008 · CA